A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
Stephen Salloway(Providence College), Paul Aisen(University of Southern California), Serge Gauthier(Texas Instruments (France)), Clifford R. Jack(Mayo Clinic), Richard J. Perrin(Washington University in St. Louis), Sarah Berman(University of Pittsburgh Medical Center), Anne M. Fagan(Washington University in St. Louis), David Wallon(Centre Hospitalier Universitaire de Rouen), Ivonne Z. Jiménez‐Velázquez(University of Puerto Rico System), Anna Santacruz(Washington University in St. Louis), Carlos Cruchaga(Washington University in St. Louis), Kelley A. Coalier(Washington University in St. Louis), William S. Brooks(UNSW Sydney), Raquel Sánchez‐Valle(Biomedical Research Networking Center on Neurodegenerative Diseases), Colin L. Masters(Mental Health Research Institute), Florence Pasquier(Centre Hospitalier Universitaire de Lille), Maïté Formaglio(Hospices Civils de Lyon), Ging‐Yuek Robin Hsiung(University of British Columbia), Jason Hassenstab(Washington University in St. Louis), Suman Jayadev(University of Washington), John C. Morris(Washington University in St. Louis), Roger Clarnette(The University of Western Australia), Eric McDade(University of Pittsburgh), Catherine J. Mummery(University College London), Martin R. Farlow(MRC Laboratory of Molecular Biology), Ghulam M. Surti(Brown University), Douglas Galasko(University of Minnesota), Guoqiao Wang(Washington University in St. Louis), Jared R. Brosch(Indiana University School of Medicine), Didier Hannequin(Hôpital Charles-Nicolle), James J. Lah(Emory University), Christopher H. van Dyck(Yale University), Erik D. Roberson(University of Alabama at Birmingham), Robert A. Koeppe(University of Michigan), Mario Masellis(Sunnybrook Health Science Centre), Peter J. Snyder(University of Connecticut), Andrew J. Aschenbrenner(Washington University in St. Louis), Alison Goate(Washington University in St. Louis), Brian A. Gordon(Mallinckrodt (United States)), Jorge J. Llibre‐Guerra(Washington University in St. Louis), Yan Li(Washington University in St. Louis), Susan L. Mills(Washington University in St. Louis), Jérémie Pariente(National Hospital for Neurology and Neurosurgery), Bruno Dubois(Portland State University), B. Joy Snider(Washington University in St. Louis), David B. Clifford(Washington University in St. Louis), Janice M. Hitchcock(Dartmouth–Hitchcock Medical Center), Tammie L.S. Benzinger(Washington University in St. Louis), Chengjie Xiong(Guangzhou Institutes of Biomedicine and Health), Lawrence S. Honig(Columbia University)
Cited by 365
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Lecanemab in Early Alzheimer’s Disease
|New England Journal of Medicine|2022|5k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k